Tag: tumor
-
![ERYTECH Pharma (ERYP.Q) has a GRASPA® on ALL, shares up +70%]()
ERYTECH Pharma (ERYP.Q) has a GRASPA® on ALL, shares up +70%
A Need for Alternatives $54.898M Market Capitalization ERYTECH Pharma (ERYP.Q) announced today that the Company has sold its US manufacturing facility to Catalent, a leading contract development and manufacturing organization (CDMO) in advanced therapies. Under the terms of the agreement, Catalent has agreed to purchase ERYTECH’s US facility for a total consideration of $44.5 million. That’s…
-
![Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases]()
Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases
In 25% of Breast Lumpectomy surgeries, cancerous material is left behind. With current technology, the surgeon needs to wait about a week, to see if he’s got all the cancerous material.
-
Perimeter Medical Imaging AI (PINK.V): the power of a simple story
No need to cut the patient open again later. The surgeon can make adjustments on the fly.
-
Perimeter Medical Imaging AI (PINK.V) shuffles the deck
PINK is accelerating toward the commercialisation of the OTIS platform. It has already received a $7.4 million grant (non-dilutive capital) from the Cancer Prevention and Research Institute of Texas (CPRIT) to fund the ATLAS AI Project.
-
Perimeter Medical Imaging AI (PINK.V) untapped value in medtech
Investing your money in health or medical companies is difficult. The complexity of the science often deters investors from allocating a portion of their portfolio to said industry, despite those companies having proven potential to provide the largest gains for its investors. We’re not criticizing – everyone knows that medical terminology is only second to…
